[ad_1]
Livongo and the University of California, San Francisco, seek to quantify the results of patients using a traditional blood glucose meter compared to those using Livongo's diabetes management program. To this end, the duo has launched a randomized controlled trial that will recruit 300 adults with type 2 diabetes.
The study will randomize patients to receive either a Bluetooth blood glucose meter and unlimited free test strips, or participate in the Livongo for Diabetes program, which includes a cell-linked glucose meter, test strips, and unlimited free trial and digital remote coaching with certified. diabetes educators. These coaches can work with users to reduce their blood glucose as quickly as possible. In addition, unlimited test strips encourage patients to check their blood sugar often without worrying about costs.
In addition to the diagnosis of type 2 diabetes, participants must be iPhone users who do not use a continuous glucose monitor or insulin pump. However, they can use any type of medication to manage their disease.
After six months of treatment, the investigators will measure the evolution of HbA1c levels in both groups.
RELATED: Fierce 15 of 2017 from FierceMedTech – Livongo
"We are interested to see how an innovative solution such as Livongo has a real impact on people," said Jenise Wong, MD, Ph.D., associate professor at UC San Francisco and senior researcher at the University of Toronto. 39 study, dubbed SUGAR, or Study to Comprand. Access the blood glucose records. "By conducting a randomized controlled trial, we can better understand how innovative offerings improve health outcomes."
The Californian company of Mountain View, Calif., Based its program on the glucometer because the majority of diabetics use it. Despite recent innovations in blood glucose monitoring and artificial pancreatic space, most patients do not use these "latest and best" tools to manage their disease, "said Amar Kendale. Product Manager at Livongo, in a previous interview.
Source link
